Beta-Alanine in Oral Pouches

Beta-alanine is an amino acid sold as a white crystalline powder and used mainly in sports and pre-workout supplements. The International Society of Sports Nutrition position stand describes supplementation at 4-6g per day for two to four weeks or more, and the efficacious range usually cited is 3.2-6.4g per day. Its best-known side effect is paresthesia, a tingling of the skin: published research reports that single oral doses larger than about 800mg commonly produce it, and the ISSN notes it as the only reported side effect.

Not at a studied dose. PouchMade's standard pouch is 0.6g, with 0.5g and 0.7g formats available, and the actives budget is typically 250-280mg per pouch, about 300mg at most; filler, flavor, and sweetener make up the rest. Even if beta-alanine took the entire 300mg ceiling, one pouch would deliver under a tenth of the low end of the daily range (300 / 3,200 = 9.4%). A 3.2g day would take 11 pouches (3,200 / 300 = 10.7), and a 6.4g day 22 pouches (6,400 / 300 = 21.3). In a real stack the budget is shared with caffeine and other actives, so the beta-alanine share would be smaller still. No inclusion rate fixes that arithmetic.

Delivery does not close the gap either. Small lipophilic molecules in the caffeine class can absorb partly through the lining of the mouth, but amino acids are charged across the whole range of mouth pH, which as a general pharmaceutics principle means poor passive movement across that tissue. Beta-alanine in a pouch is largely carried by saliva and swallowed, and there is no pouch-specific absorption data for it.

There is one side effect of the math worth knowing: the 300mg actives ceiling sits well below the roughly 800mg single-dose level where tingling becomes common. So a pouch-scale inclusion is unlikely to tingle, and equally unlikely to deliver what the studies measured.

There is effectively no pouch market for beta-alanine to benchmark. In a PouchMade review of about 36 non-nicotine pouch formulas on major US marketplaces in September 2026, none listed beta-alanine at all, dosed or undosed. Nor did any product in a wider census of about 198 pouch products. Formulas in that review centered on caffeine, B vitamins, nootropics, adaptogens, and electrolytes instead. The capacity arithmetic above is the likely reason.

If a brand includes beta-alanine as a minor label ingredient, the formulation cost is payload rather than flavor: every milligram of beta-alanine is a milligram not available for caffeine, flavor, or the filler that buffers moisture. We have no pouch-specific taste or stability data for beta-alanine, so any inclusion should go through bench trials and finished-pouch stability testing like any other new active. The tingling it is known for is a whole-body sensory effect, not a mouthfeel effect, and at pouch-scale inclusion it should not appear.

Identity testing is where amino acids catch manufacturers out. Beta-alanine, taurine, glycine, and creatine are all white powders, and 21 CFR 111.75 requires an appropriate, scientifically valid identity test on every lot; visual or organoleptic checks cannot tell them apart, and a supplier CoA cannot substitute for the test. We did not locate a USP monograph for beta-alanine, so the working approach is:

• Identity: FTIR against a qualified reference material.
• Assay: HPLC against a certified beta-alanine standard.
• Substitution screen: beta-alanine substitution is a named adulteration risk in GABA lots, and the same logic applies in reverse, so the method should rule out other amino acids.
• Heavy metals and microbial: lead, arsenic, cadmium, and mercury by ICP-MS to USP <2232> limits, plus the USP dietary supplement microbial chapters.

Beta-alanine is not a simple pre-1994 assumption. Natural Alternatives International filed New Dietary Ingredient notification 1103 for its CarnoSyn beta-alanine in 2018, and FDA acknowledged the filing in February 2019 without objection. The notified conditions of use are 800mg to 1.6g per serving, up to four times a day, maximum 6.4g per day, adults only. That notification covers that company's material. FDA's notification list shows one other beta-alanine filing, whose response we have not reviewed, and FDA has not said beta-alanine as such was marketed before 1994 the way it has for GABA. A brand should either use material covered by a notification that fits its intended use or document a pre-1994 marketing basis with counsel. Those conditions describe gram-scale servings, and how a much smaller pouch serving maps onto them is a question for regulatory counsel.

Beta-alanine is not a Proposition 65 listed chemical, and it is not named in Amazon's dietary supplement policy. Claims are the larger trap. FTC substantiation has to match the product's dose and form, so performance claims drawn from 4-6g per day studies cannot be carried by a pouch delivering a few hundred milligrams. Structure/function language only, with the DSHEA disclaimer.

Our honest recommendation: if beta-alanine is the point of the product, a powder or capsule is the right format. If you are building a sports or energy pouch, the actives that suit the format at a meaningful dose, starting with caffeine at 0-200mg per pouch, belong at the center of the stack. Related amino acids face the same wall; see creatine and taurine. For functional pouch briefs that still want beta-alanine on the label, PouchMade works through feasibility and dosing in custom formulation at its FDA-registered, GMP-certified Dallas, Texas facility.